Index

Recent articles

Spectrum Index: Self-harm hospitalizations, everolimus flops in phase 2 trial

This month’s newsletter also highlights deflated autism prevalence estimates from Shanghai, China.

By Niko McCarty
30 May 2022 | 3 min read

Spectrum Index: Dip in autism screening, null cancer risk, therapist surge

This month’s newsletter looks at a decline in well-child visits during the coronavirus pandemic, the autism-cancer connection and the sizeable fraction of autistic children who live in poverty.

By Niko McCarty
28 April 2022 | 2 min read

Spectrum Index: Rare genetic diagnoses, obesity odds, violence against children

This month’s newsletter looks at the minority of autistic people who have an identifiable genetic cause for their condition, and at the fraction of autistic children who are obese.

By Niko McCarty
31 March 2022 | 3 min read

Spectrum Index: IQ deviations, rural disparities and underweight infants

This monthly newsletter offers quick statistics on the latest data-centric, autism research studies.

By Niko McCarty
23 February 2022 | 3 min read

Explore more from The Transmitter

Cell population in brainstem coordinates cough, new study shows

The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.

By Calli McMurray
6 September 2024 | 5 min read
Capitol building
Spectrum Microphone

In updated U.S. autism bill, Congress calls for funding boost, expanded scope

The current Autism CARES Act sunsets in late September.

By Rachel Zamzow
5 September 2024 | 5 min listen
Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.

Ketamine targets lateral habenula, setting off cascade of antidepressant effects

The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.

By Olivia Gieger
4 September 2024 | 6 min read